Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

July 31, 2027

Conditions
DepressionInflammationAntidepressantsImmunity
Interventions
DRUG

SSRI

"Outpatients with a diagnosis of major depression in the Psychiatry Outpatient Clinics will be evaluated for recruitment.~* Recruitment visit: It will be carried out by one of the psychiatrists participating in the study. The patient will be informed about the study and written consent will be requested. Subsequently, the inclusion and exclusion criteria will be reviewed, and all demographic and clinical variables will be collected.~* Baseline visit: One of the psychiatrists will interview the patient and apply the semi-structured clinical interview and the psychopathological evaluation questionnaires. In addition, a blood draw will be performed for serum collection, spectral cytometric analysis of lymphocyte subpopulations and obtaining peripheral blood mononuclear cells (PBMCs).~* Follow-up visit after 3 months of treatment: Clinical variables will be collected and the same procedures will be performed as during the baseline visit. Not in the control group."

Trial Locations (1)

08916

Hospital Universitari Germans Trias i Pujol, Badalona

All Listed Sponsors
lead

Germans Trias i Pujol Hospital

OTHER

NCT06337539 - Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants | Biotech Hunter | Biotech Hunter